awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40194507-2C4E5E42-9071-4B54-A4E4-2D809DBF1ED5
Q40194507-2C4E5E42-9071-4B54-A4E4-2D809DBF1ED5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40194507-2C4E5E42-9071-4B54-A4E4-2D809DBF1ED5
Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.
P2860
Q40194507-2C4E5E42-9071-4B54-A4E4-2D809DBF1ED5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40194507-2C4E5E42-9071-4B54-A4E4-2D809DBF1ED5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc1776e11b2c431c7be0a1e29f4e9c64a6e7909d
P2860
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res